Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical and Histopathologic Characteristics of BAP1 Mutations

NCT01773655 is registered in ClinicalTrials.gov with Memorial Sloan Kettering Cancer Center as lead sponsor.

NCT NCT01773655
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01773655 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical and Histopathologic Characteristics of BAP1 Mutations
Lead sponsor
Memorial Sloan Kettering Cancer Center
Phase
Observational
Overall status
Completed
Start date
January 31, 2013
Completion date
June 30, 2020
Enrollment
196 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

cholangiocarcinoma, choroidal nevus, malignant pleural mesothelioma (mpm), metastatic uveal melanoma (um), primary uveal melanoma (um), renal cell carcinoma